Broad and deep data for entire drug lifecycle
Scientific literature monitoring & KOL identification
- Extract and organize content from the literature and databases to learn from research around your target indication or molecule
- Supplement and enhance your searches with fully integrated information on companies and research institutes, current biomedical literature and the most recent patient literature
- Identify the key opinion leaders who can provide advice around drug development or clinical trial planning
Molecular pathway analysis & bioinformatics
- Understand the meaning of your omics data in the context of healthy and diseased molecular pathways
- Link drugs, targets and genes to biomarker information from a diverse range of sources
- Rapidly generate and validate hypotheses for novel biomarkers, targets and mechanisms of action
Preclinical drug development
- Compare your drug’s preclinical performance to prior research
- Access scientific pipeline data that is easily searchable in one platform
- Help drive innovation and support earlier decision-making when developing new hypotheses for new targets, drugs and biomarkers
- Learn from the success of your peers with comprehensive coverage of pipeline data, patents, literature and conferences – all from a scientific perspective
Clinical trial planning & feasibility
- Understand the successful protocols, sites or patient segments for drugs in your therapeutic area
- Generate testable hypotheses for patient stratification, biomarker discovery, disease understanding, target identification, drug combination effect prediction and drug repositioning
- Explore disease therapy areas, interventions, phases, recruitment status, start and end dates, sites, sponsors and collaborators, actions and drug classes, patient segment and eligibility criteria, inclusion criteria including gene variants, biomarkers, endpoints, combination therapies, trial designs, results and adverse events
